Biosynthesis of the glycosaminoglycan precursor UDP-α-D-glucuronic acid occurs through a 2-fold oxidation of UDP-α-D-glucose that is catalysed by UGDH (UDP-α-D-glucose 6-dehydrogenase). Structure–function relationships for UGDH and proposals for the enzymatic reaction mechanism are reviewed in the present paper, and structure-based sequence comparison is used for subclassification of UGDH family members. The eukaryotic group of enzymes (UGDH-II) utilize an extended C-terminal domain for the formation of complex homohexameric assemblies. The comparably simpler oligomerization behaviour of the prokaryotic group of enzymes (UGDH-I), in which dimeric forms prevail, is traced back to the lack of relevant intersubunit contacts and trimmings within the C-terminal region. The active site of UGDH contains a highly conserved cysteine residue, which plays a key role in covalent catalysis. Elevated glycosaminoglycan formation is implicated in a variety of human diseases, including the progression of tumours. The inhibition of synthesis of UDP-α-D-glucuronic acid using UGDH antagonists might therefore be a useful strategy for therapy.
UDP-glucose dehydrogenase: structure and function of a potential drug target
- Views Icon Views
- Share Icon Share
- Cite Icon Cite
Sigrid Egger, Apirat Chaikuad, Kathryn L. Kavanagh, Udo Oppermann, Bernd Nidetzky; UDP-glucose dehydrogenase: structure and function of a potential drug target. Biochem Soc Trans 1 October 2010; 38 (5): 1378–1385. doi: https://doi.org/10.1042/BST0381378
Download citation file: